文献速递乳腺外科

乳房切除术后放疗:永久假体与组织扩张器哪个更优?

Postmastectomy Radiation Therapy on Permanent Implants or Tissue Expanders: Which is Better?
PubMed 文献 · Ann Surg · 2021-01-01

该单中心回顾性研究纳入1566例乳房切除术后假体再造患者,其中265例接受放疗(永久假体149例,组织扩张器116例)。放疗时放置组织扩张器者总体并发症、皮肤坏死、伤口裂开、感染及取出假体率均高于永久假体者,再造失败率也更高(21.6% vs 11.4%;P=0.025)。

要点

  • 放疗时放置组织扩张器者并发症和再造失败率高于永久假体者。
  • 放疗 boost 是并发症的预测因素(OR 2.199,95%CI 1.154-4.188,P=0.017)。
  • 多变量分析显示扩张器放疗的再造失败风险高于永久假体(OR 2.020,95%CI 1.010-4.037,P=0.047)。

核心结论

  • 多数患者乳房切除术后放疗后假体再造成功。
  • 直接永久假体再造后放疗的并发症和再造失败率低于组织扩张器-假体再造。

研究设计与样本

  • 单中心回顾性综述,随访2至10年。
  • 共1566例患者,265例接受放疗(149例永久假体,116例组织扩张器)。

主要发现

  • 扩张器放疗组总体并发症32.8% vs 11.4%(P<0.001)。
  • 扩张器放疗组皮肤坏死10.3% vs 4.0%(P=0.043)。
  • 扩张器放疗组伤口裂开9.5% vs 2.7%(P=0.029)。
  • 扩张器放疗组感染16.4% vs 4.03%(P=0.001),导致取出假体率16.4% vs 4.0%(P<0.001)。
  • 扩张器放疗组再造失败率21.6% vs 11.4%(P=0.025);包膜挛缩修正率两组相似(11.4% vs 11.2%;P=0.959)。

关键数值与推荐

  • 放疗 boost 预测并发症:OR 2.199,95%CI 1.154-4.188,P=0.017。
  • 扩张器放疗 vs 永久假体放疗的再造失败:OR 2.020,95%CI 1.010-4.037,P=0.047。

临床怎么用

  • 乳房切除术后需放疗且计划假体再造时,可优先考虑直接永久假体再造以降低并发症和失败风险。
  • 若放疗时放置组织扩张器,应警惕皮肤坏死、伤口裂开、感染及取出假体风险。

局限性

  • 单中心回顾性研究,可能存在选择偏倚。
  • 扩张器组吸烟者比例更高(7.7% vs 1.3%;P=0.012),可能影响并发症比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study evaluates complications and reconstructive failure rates in implant-based reconstruction with radiotherapy. BACKGROUND: Postmastectomy radiotherapy may adversely affect breast reconstructive outcomes. However, the comparative effect of radiotherapy on direct-to-implant versus tissue expander-implant reconstruction has not been examined. METHODS: Single institution retrospective review was performed and patients were followed 2 to 10 years. RESULTS: Of 1566 patients, 265 patients received radiation (149 immediate implants and 116 tissue expanders). Demographics were similar except more smokers in the expander group (7.7% vs 1.3%; P = 0.012). Patients who received radiation with an expander in place had overall more complications (32.8% vs 11.4%; P < 0.001), skin necrosis (10.3% vs 4.0%; P = 0.043), wound breakdown (9.5% vs 2.7%; P = 0.029), and infections (16.4% vs 4.03%; P = 0.001) leading to a higher rate of explantation (16.4% vs 4.0%; P < 0.001). A radiation boost likewise predicted complications [odds ratio (OR) 2.199, 95% confidence interval (CI) 1.154-4.188, P = 0.017]. When comparing reconstructive outcomes, radiated expanders had a higher failure rate (21.6% vs 11.4%; P = 0.025). Revision for capsular contracture was similar between the 2 cohorts (11.4% vs 11.2%; P = 0.959) as were revision rates for contour asymmetry and breast asymmetry. In our multivariable logistic regression analysis, radiation to the expander had a higher risk of reconstruction failure than radiation to the permanent implant (OR 2.020, 95% CI 1.010-4.037, P = 0.047). CONCLUSION: Most patients had successful implant-based reconstructions after mastectomy and radiotherapy. Our study showed radiotherapy after direct-to-implant breast reconstruction had a lower rate of complications and reconstructive failure compared to tissue expander-implant reconstruction.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Lin AM, Christensen JM, Liao EC, et al. Postmastectomy Radiation Therapy on Permanent Implants or Tissue Expanders: Which is Better? Ann Surg. 2021. PMID: 31714307. doi:10.1097/SLA.0000000000003670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。